195 results on '"Tricot, Sabine"'
Search Results
2. Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)
3. Leukocytospermia induces intraepithelial recruitment of dendritic cells and increases SIV replication in colorectal tissue explants
4. Supplemental Table 3 Characteristics of patients with WM according to CXC4 mutation status from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
5. Supplemental Table 1 Gene expression profilling from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
6. Supplementary Table 1, Supplementary Figures 1-4 from TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
7. List of pathways analyzed for GSEA from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
8. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
9. Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
10. Large α-aminonitrilase activity screening of nitrilase superfamily members: Access to conversion and enantiospecificity by LC–MS
11. MYD88 L265P mutation in Waldenstrom macroglobulinemia
12. Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma
13. Additional file 3 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
14. Additional file of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
15. Additional file 11 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
16. Additional file 5 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
17. Additional file 6 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
18. Additional file 9 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
19. Additional file 7 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
20. Additional file 4 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
21. Diagnostic histologique de lymphome intravasculaire guidé par une hyperfixation corticale rénale à la tomographie par émission de positons : à propos d’un cas
22. A conserved gene cluster rules anaerobic oxidative degradation of L-ornithine
23. Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia
24. Microbial urate catabolism: characterization of HpyO, a non-homologous isofunctional isoform of the flavoprotein urate hydroxylase HpxO
25. TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia
26. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
27. Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2 rearrangement
28. Thalidomide in multiple myeloma in the elderly
29. Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
30. Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study
31. Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
32. Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study
33. Cytogenetic landscape in 1012 newly diagnosed chronic lymphocytic leukemia
34. Targeting MOG to skin macrophages prevents EAE in macaques through TGFβ-induced peripheral tolerance
35. The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models
36. Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence
37. Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
38. Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
39. TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
40. Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
41. Fibered Confocal Fluorescence Microscopy for the Noninvasive Imaging of Langerhans Cells in Macaques
42. Evaluating the Efficiency of Isotope Transmission for Improved Panel Design and a Comparison of the Detection Sensitivities of Mass Cytometer Instruments
43. Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
44. TP53 Mutation in Waldenstrom Macroglobulinemia
45. BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia
46. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
47. Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study
48. Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?
49. Absence ofCXCR4mutations but high incidence of double mutant inCD79A/BandMYD88in primary central nervous system lymphoma
50. Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.